Study cohort n = 73 | |
---|---|
Age, median (IQR) | 66 (54–76) |
Weight, kg, median (IQR) | 79 (65–85) |
Male, n (%) | 48 (66) |
Preexisting cardiac disease*, n (%) | 38 (52) |
Apache II score, median (IQR) | 20 (16–26) |
SOFA score on admission, median (IQR) | 11 (8–13) |
Mechanically ventilated during echocardiography, n (%) | 55 (75) |
PEEP, cmH2O, median (IQR) | 8 (7–12) |
Mechanical ventilation days, median (IQR) | 6 (3–13) |
CRRT, n (%) | 15 (21) |
Vasopressors/inotropes during echocardiography, n (%) | 65 (89) |
hsTnT (ng/L), median (IQR) | 79 (37–201) |
ICU length of stay days, median (IQR) | 7 (4–12) |
ICU mortality, n (%) | 15 (21) |
30-day mortality, n (%) | 18 (25) |
Regional wall motion abnormality, n (%) | 9 (12%) |
% with LVEF ≤ 50% | 54% |
LVLS, %, median (IQR) | − 15.0 (− 10.7–− 18.6) |
MAPSE, mm, median (IQR) | 10.3 (7.2–13.0) |
LWFS, %, median (IQR) | 11.7 (8.3–14.2) |